Skandinaviska Enskilda Banken (SEB)’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,731
| Closed | -$909K | – | 850 |
|
|
2025
Q1 | $909K | Hold |
3,731
| – | – | ﹤0.01% | 650 |
|
|
2024
Q4 | $1.22M | Sell |
3,731
-100
| -3% | -$32.6K | 0.01% | 637 |
|
|
2024
Q3 | $1.28M | Hold |
3,831
| – | – | 0.01% | 649 |
|
|
2024
Q2 | $1.05M | Hold |
3,831
| – | – | 0.01% | 639 |
|
|
2024
Q1 | $1.33M | Hold |
3,831
| – | – | 0.01% | 638 |
|
|
2023
Q4 | $1.24M | Sell |
3,831
-158
| -4% | -$51K | 0.01% | 662 |
|
|
2023
Q3 | $1.43M | Sell |
3,989
-17
| -0.4% | -$6.09K | 0.01% | 616 |
|
|
2023
Q2 | $1.52M | Buy |
4,006
+132
| +3% | +$50.1K | 0.01% | 618 |
|
|
2023
Q1 | $1.86M | Sell |
3,874
-94
| -2% | -$45K | 0.01% | 567 |
|
|
2022
Q4 | $1.67M | Buy |
3,968
+284
| +8% | +$119K | 0.01% | 576 |
|
|
2022
Q3 | $1.54M | Sell |
3,684
-1,122
| -23% | -$468K | 0.01% | 594 |
|
|
2022
Q2 | $2.38M | Sell |
4,806
-401
| -8% | -$198K | 0.02% | 527 |
|
|
2022
Q1 | $2.93M | Sell |
5,207
-485
| -9% | -$273K | 0.02% | 532 |
|
|
2021
Q4 | $4.32M | Sell |
5,692
-160
| -3% | -$121K | 0.02% | 452 |
|
|
2021
Q3 | $4.37M | Buy |
5,852
+68
| +1% | +$50.7K | 0.02% | 445 |
|
|
2021
Q2 | $3.73M | Buy |
5,784
+334
| +6% | +$215K | 0.02% | 483 |
|
|
2021
Q1 | $3.11M | Buy |
5,450
+57
| +1% | +$32.6K | 0.02% | 521 |
|
|
2020
Q4 | $3.14M | Sell |
5,393
-69
| -1% | -$40.2K | 0.02% | 498 |
|
|
2020
Q3 | $2.82M | Buy |
5,462
+3,841
| +237% | +$1.98M | 0.02% | 471 |
|
|
2020
Q2 | $732K | Buy |
1,621
+221
| +16% | +$99.8K | 0.01% | 766 |
|
|
2020
Q1 | $491K | Buy |
1,400
+100
| +8% | +$35.1K | 0.01% | 748 |
|
|
2019
Q4 | $481K | Buy |
+1,300
| New | +$481K | ﹤0.01% | 803 |
|